FDA promoting innovative clinical trial designs as part of new pilot program
The FDA has launched a new pilot program targeting complex, innovative clinical trials designs as part of its commitment under PDUFA VI.
The FDA has launched a new pilot program targeting complex, innovative clinical trials designs as part of its commitment under PDUFA VI.
Horizon Discovery is collaborating with a global pharmaceutical company to develop and apply single cell RNAseq-linked pooled CRISPR screening.
Researchers from the Clinic for Special Children have developed a drug delivery catheter system that could reach a larger population of patients receive Biogen’s Spinraza treatment.
Rekah Pharmaceuticals will take on the responsibility of manufacturing certain products within Teva’s portfolio in Israel.
Tjoapack and Veratrak partnered to establish the use of blockchain technology across the pharmaceutical industry for the first time in a GxP environment.